Two phase 3 trials are set to test the efficacy and safety of IW-3718 — a novel formulation of the bile acid sequestrant colesevelam — for treating GERD, according to the manufacturer Ironwood Pharmaceuticals.
https://www.healio.com/gastroenterology/esophagus/news/online/%7B59304d52-4d48-4a19-85eb-6ed6ac2fd7b0%7D/phase-3-trials-to-test-efficacy-safety-of-bile-acid-sequestrant-for-gerd
Phase 3 trials to test efficacy, safety of bile acid sequestrant for GERD